Robert Wessman Staircase@2x
Company

A fast growing pharma leader 

Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world.

Strategic roadmap
Robert WessmanChairman and CEO
Preferred partner

A major player driving change 

The company has commercial operations in 35 countries with 2,800 employees and operates five manufacturing and development hubs in the U.S., Romania, Korea and Taiwan.

35
Worldwide
offices
Search

Meet our management 

Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safely to market.

2,800
Global
employees
Meet the team
Robert Wessman
Helga Gudlaugsdottir
Michael Harris
Arni Hardarson
Christine Wells
Martina Feitzinger
Alvotech alvogen office

Lines of business 

Alvogen's lines of business include: product development, contract manufacturing and research (CMO), and sales of generic medicines (Gx and Hx), biosimilars and OTC.

Alvogen's product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology, in addition to a fast-growing portfolio of biosimilars and OTC products.

350
Marketed products
Products
temp-bg-trans
Join us

Interested in joining the team? 

We are on a journey to build a leading global generics company. We are determined to meet our goals and we will have fun along the way. Are you interested in joining the team? We're always excited to hear from great people. Take a look at our current job openings or send us your resume.

We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. Learn more.